Previous close | 11.65 |
Open | 10.99 |
Bid | 11.00 x 100 |
Ask | 11.01 x 300 |
Day's range | 10.48 - 11.16 |
52-week range | 10.48 - 15.15 |
Volume | |
Avg. volume | 1,998,659 |
Market cap | 1.44B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.05 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 25.75 |
Dynavax Technologies Corporation (NASDAQ:DVAX) Q1 2024 Earnings Call Transcript May 8, 2024 Dynavax Technologies Corporation misses on earnings expectations. Reported EPS is $-0.06698 EPS, expectations were $-0.05. DVAX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Dynavax […]
Explore the key financial outcomes and strategic insights from Dynavax Technologies Corp's first quarter of 2024, including significant revenue growth and enhanced gross margins.
Dynavax Technologies (DVAX) delivered earnings and revenue surprises of -40% and 2.29%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?